GBP1 and breast carcinoma: Finally, an extensive analysis of microarray data in breast cancers indicates that hGBP-1 and hGBP-5 are robustly induced in a subset of basal-like triple negative breast cancers with greater than 80% recurrence free survival for 10 years [9].